BrightEdge Fund

BrightEdge Fund

The American Cancer Society’s donor-funded, philanthropic impact fund in Atlanta that invests in companies developing novel cancer-focused therapies and technologies

BrightEdge Fund is the American Cancer Society’s donor-funded, philanthropic impact fund in Atlanta that invests in companies developing novel cancer-focused therapies and technologies. Founded 2018 in Atlanta, Georgia, United States, this corporate venture capital firm invests in early stage ventures. Its portfolio companies include Tmunity Therapeutics, Navigating Cancer, Freenome, and Castle Biosciences. As of February 2020, BrightEdge Fund has made 4 investments. Their most recent investment was on Oct 31, 2019, when Tmunity Therapeutics raised $75M. BrightEdge Fund has had 1 exit, which was Castle Biosciences.

Timeline

2018

Founded

Funded Companies

Company
Industry
Website
Location
Navigating Cancer
Software as a service (SaaS)
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

David Heenan

Director of Operations

Robert Crutchfield

Managing Director

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Castle Biosciences

Freenome

Navigating Cancer

Tmunity Therapeutics

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.